In a transactional environment that requires more creativity, savvy and interdisciplinary know-how than ever before to get deals done, our Mergers & Acquisitions Group brings everything to the table to complete transactions involving all aspects of buying, selling and combining companies and businesses. From the middle to the high end of the market, we advise clients on matters in nearly every major business sector, including business services, chemicals, defense, entertainment, financial services, life sciences, lodging and gaming, manufacturing, publishing, real estate, retail, sports, technology and telecommunications.
In addition to the volume of U.S. representations in which we are involved, our cross-border transactions comprise a significant part of the work we do for our global client base, including clients in the U.S. acquiring and disposing of assets held by companies outside the country. We also regularly represent clients in joint ventures from the planning stages through implementation, always with an eye towards creating effective, practical structures to achieve optimum results. Our deep knowledge of private equity and access to the latest market trends provide our clients with a strategic advantage in a competitive and complex environment.
Our group has been consistently recognized by leading ranking publications for our work around the world, with Chambers USA noting our clients’ praise for our “outstanding service on massively important and crucial corporate issues” and “responsive attorneys who really think creatively about solutions,” and US Legal 500 recognizing our “in-depth industry knowledge” and “highest quality legal advice”. Our team also appears on Thomson Reuters, Bloomberg and mergermarket league tables, in the U.S. and globally for involvement in completed deals.
Areas of Focus
Accor S.A. in its pending $1.9 billion sale of its United States Economy Hotels Division (including Motel 6 and Studio 6) to Blackstone Real Estate Partners VII
Ares Corporate Opportunities Fund III, LP and Canada Pension Plan Investment Board in their $1.6 billion acquisition of retail chain 99 Cents Only Stores
Grifols S.A., a global health care company and leading producer of plasma protein therapies, in its $4 billion acquisition of Talecris Biotherapeutics, creating a global leader of life-saving and life-enhancing plasma protein therapies